Primary intraocular lymphoma: Treatment outcomes with ocular radiation therapy alone

Leukemia and Lymphoma

Volumn 55, Issue 4, 2014, Pages 795-801

  Teckie, Sewit ^a   Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Ocular radiation therapy; Primary central nervous system lymphoma; Primary intraocular lymphoma

Indexed keywords

BEVACIZUMAB; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; RITUXIMAB; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRAOCULAR LYMPHOMA; MALE; OVERALL SURVIVAL; PRIMARY INTRAOCULAR LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TREATMENT OUTCOME; BIOPSY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SALVAGE THERAPY; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; INTRAOCULAR LYMPHOMA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84904343480     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.819576     Document Type: Article

References (22)

1. CoteTR, Manns A, Hardy CR, et al. Epidemiology of brainlymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-679. (Pubitemid 26152554)
2. Peterson K, Gordon KB, Heinemann MH, et al. The clinical spectrum of ocular lymphoma. Cancer 1993;72:843-849. (Pubitemid 23215274)
3. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999;106:1805-1810. (Pubitemid 30194285)
4. Freeman LN, Schachat AP, Knox DL, et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987; 94: 1631-1639. (Pubitemid 18006894)
5. Levy-Clarke GA, Chan CC, Nussenblatt RB. Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am 2005; 19: 739-749, viii.
6. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988;68:835-853.
7. Ferreri AJ, Abrey LE, Blay JY, et al. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. J Clin Oncol 2003;21:2407-2414. (Pubitemid 46621879)
8. DeAngelis LM, Seiferheld W, Schold SC, et al. Radiation Therapy Oncology Group S. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002;20:4643-4648. (Pubitemid 36025280)
9. Berenbom A, Davila RM, Lin HS, et al. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye (Lond) 2007;21:1198-1201. (Pubitemid 47382147)
10. Hormigo A, DeAngelis LM. Primary ocular lymphoma: clinical features, diagnosis, and treatment. Clin Lymphoma 2003; 4: 22-29. (Pubitemid 36826872)
11. Isobe K, Ejima Y, Tokumaru S, et al. Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan. Leuk Lymphoma 2006;47:1800-1805. (Pubitemid 44649763)
12. Hormigo A, Abrey L, HeinemannMH, et al. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 2004; 126: 202-208. (Pubitemid 38961938)
13. Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 2002;109:1709-1716. (Pubitemid 35012013)
14. Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of rituximab. Eye (Lond) 2007; 21: 1524-1527.
15. Vosganian GS, Boisot S, Hartmann KI, et al. Primary intraocular lymphoma: a review.J Neurooncol 2011; 105: 127-134.
16. Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lym- phoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol 2007;18:1851-1855. (Pubitemid 350111571)
17. Ferreri AJ, Blay JY, Reni M, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 2003;21:266-272. (Pubitemid 46606155)
18. Jahnke K, Thiel E, Abrey LE, et al. Diagnosis and management of primary intraocular lymphoma: an update. Clin Ophthalmol 2007;1:247-258.
19. Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology 2008; 71: 1355-1360.
20. Batchelor TT, Kolak G, Ciordia R, et al. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 2003; 9: 711-715. (Pubitemid 36182604)
21. Jahnke K, Wagner T, Bechrakis NE, et al. Pharmacokinetics and efficacy of ifosfamide or trofosfamide in patients with intraocular lymphoma. Ann Oncol 2005; 16: 1974-1978. (Pubitemid 41724289)
22. Fishburne BC, Wilson DJ, Rosenbaum JT, et al. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997; 115: 1152-1156. (Pubitemid 27387951)